Tirzepatide, the active ingredient in Mounjaro and Zepbound, reduced sleepapnea symptoms for people with obesity. The drug improved sleepapnea symptoms whether or not people used a PAP ...
A late-stage trial of Eli Lilly’s weight loss drug Zepbound showed promising results in treating sleepapnea symptoms in obese adults, the company announced Wednesday, the latest findings ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some ...
Some results have been hidden because they may be inaccessible to you